| 8114879 |
Piperazine derivatives useful as CCR5 antagonists |
Bahige M. Baroudy, John W. Clader, Hubert Josien, Brian McKittrick, Michael Miller +9 more |
2012-02-14 |
|
| 7750158 |
Cannabinoid receptor ligands |
Bandarpalle B. Shankar, Eric J. Gilbert, Razia Rizvi, Chunli Huang, Joseph A. Kozlowski +1 more |
2010-07-06 |
|
| 7705019 |
Piperidinyl piperidine derivatives useful as inhibitors of chemokine receptors |
Tze-Ming Chan, Kathleen Cox, Wenqing Feng, Michael Miller, Daniel Weston |
2010-04-27 |
|
| 7705153 |
Bipiperdine derivatives useful as CCR3 antagonists |
Pauline C. Ting, Jianhua Cao, Youhao Dong, Eric J. Gilbert, Ying Huang +2 more |
2010-04-27 |
|
| 7659275 |
Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors |
Tze-Ming Chan, Kathleen Kox, Wenqing Feng, Michael Miller, Daniel Weston |
2010-02-09 |
|
| 7384944 |
Piperazine derivatives useful as CCR5 antagonists |
Bahige M. Baroudy, John W. Clader, Hubert Josien, Brian McKittrick, Michael Miller +9 more |
2008-06-10 |
$175,193,000 |
| 7309704 |
Heteroaryl urea neuropeptide Y Y5 receptor antagonists |
Andrew Stamford, Youhao Dong, Yusheng Wu |
2007-12-18 |
$81,497,000 |
| 6982267 |
Heteroaryl urea neuropeptide Y Y5 receptor antagonists |
Andrew Stamford, Youhao Dong, Yusheng Wu |
2006-01-03 |
$72,918,000 |
| 6946476 |
Heteroaryl urea neuropeptide Y Y5 receptor antagonists |
Andrew Stamford, Youhao Dong, Yusheng Wu |
2005-09-20 |
$155,047,000 |
| 6894063 |
Substituted urea neuropeptide Y Y5 Receptor antagonists |
William J. Greenlee, Ying Huang, Joseph M. Kelly, Andrew Stamford, Yusheng Wu |
2005-05-17 |
$39,337,000 |
| 6689765 |
Piperazine derivatives useful as CCR5 antagonists |
Bahige M. Baroudy, John W. Clader, Hubert Josien, Brian McKittrick, Michael Miller +9 more |
2004-02-10 |
$44,502,000 |
| 6602885 |
Piperidine derivatives useful as CCR5 antagonists |
Bahige M. Baroudy, John W. Clader, Hubert Josien, Brian McKittrick, Michael Miller +6 more |
2003-08-05 |
$209,158,000 |
| 6498168 |
Muscarinic antagonists |
Derek Lowe, Wei K. Chang, Joseph A. Kozlowski, Joel G. Berger, Robert McQuade +14 more |
2002-12-24 |
$316,470,000 |
| 6451797 |
Muscarinic antagonists |
Joseph A. Kozlowski, Jayaram R. Tagat, Susan F. Vice |
2002-09-17 |
$99,496,000 |
| 6391865 |
Piperazine derivatives useful as CCR5 antagonists |
Bahige M. Baroudy, John W. Clader, Hubert Josien, Brian McKittrick, Michael Miller +8 more |
2002-05-21 |
$155,179,000 |
| 6387930 |
Piperidine derivatives useful as CCR5 antagonists |
Bahige M. Baroudy, John W. Clader, Hubert Josien, Brian McKittrick, Michael Miller +6 more |
2002-05-14 |
$78,742,000 |
| 6294554 |
Muscarinic antagonists |
John W. Clader, Joseph A. Kozlowski, Michael Miller, Susan F. Vice |
2001-09-25 |
$270,411,000 |
| 6288068 |
Muscarinic antagonists |
Derek Lowe, Wei K. Chang, Joseph A. Kozlowski, Joel G. Berger, Robert McQuade +14 more |
2001-09-11 |
|
| 6066636 |
Muscarinic antagonists |
Joseph A. Kozlowski, Jayaram R. Tagat, Susan F. Vice |
2000-05-23 |
$825,429,000 |
| 6043255 |
Muscarinic antagonists |
Derek Lowe, Wei K. Chang, Joseph A. Kozlowski, Joel G. Berger, Robert McQuade +15 more |
2000-03-28 |
$211,491,000 |
| 6037352 |
Muscarinic antagonists |
Derek Lowe, Wei K. Chang, Joseph A. Kozlowski, Joel G. Berger, Robert McQuade +14 more |
2000-03-14 |
$302,746,000 |
| 5889006 |
Muscarinic antagonists |
Derek Lowe, Wei K. Chang, Joseph A. Kozlowski, Joel G. Berger, Robert McQuade +15 more |
1999-03-30 |
$271,440,000 |
| 5883096 |
Muscarinic antagonists |
Derek Lowe, Wei K. Chang, Joseph A. Kozlowski, Joel G. Berger, Robert McQuade +14 more |
1999-03-16 |
$290,907,000 |
| 5318971 |
3-Substituted-1-aryl-2(1H)-quinolones useful as anti-allergy and anti-inflammatory agents |
— |
1994-06-07 |
$69,085,000 |
| 5179093 |
Quinoline-diones |
Adriano Afonso, Jay Weinstein |
1993-01-12 |
$19,584,000 |